We retrospectively reviewed all enrollments in three Phase-III acute stroke clinical trials (NCT03735979, NCT03785678, NCT02864953) enrolled at our tertiary stroke center (Fairview Southdale Hospital) from June 30, 2019 - April 30, 2022. We compared demographics (age, gender, race, ethnicity, and primary language [English: yes/no]) of cohort enrolled in clinical trials versus demographics of general stroke patient population utilizing chi-squared testing and descriptive statistics.
Sixty-eight patients were enrolled in acute stroke trials (34 in MOST,30 in TIMELESS, 4 in CHARM) with a median age of 71 (IQR 20.25) at Fairview Southdale Hospital.
Race Enrollment Patient Population
White 86.76% (59) 86.7% (2282)
Black/African
American 5.88% (4) 5.7% (149)
Asian 4.41% (3) 3% (79)
Others 1.47% (1) 4.6% (121)
Language Enrollment Patient population
English 94.1% (64) 96.6% (2526)
Somali 2.94% (2) 0.535% (14)
Vietnamese 1.47% (1) 0.46% (12)
Others 1.47% (1). 2.5% (63)
Ethnicity Enrollment Patient Population
Non-Hispanic 94.1% (64) 79.51% (2079)
Hispanic or Latino 1.47% (1) 1.68% (44)
Others/Unknown 4.41% (3) 18.81% (492)
Gender Enrollment Patient Population
Male 51% (35) 47% (1496)
Female 49% (33) 53% (1688)